Matches in SemOpenAlex for { <https://semopenalex.org/work/W2146156310> ?p ?o ?g. }
- W2146156310 endingPage "92" @default.
- W2146156310 startingPage "787" @default.
- W2146156310 abstract "Androgen ablation is palliative and does not cure advanced prostate cancer. The hormone-sensitive cells die and the hormone-resistant cells overgrow, resulting in disease progression. The drug of choice for secondary treatment is estramustine (Estracyt). The success of the therapy is followed by changes of the prostate-specific antigen level and Karnofsky scale. In the present study, the results of estramustine treatment of 79 patients with advanced prostate cancer in 12 hospitals were evaluated. The mean prostate-specific antigen level improved for 6 months, but rose from the ninth month on. The improvement in the subjective condition of the patients paralleled the change in the prostate-specific antigen level. The short time of improvement was a consequence of the very high prostate-specific antigen level and the poor general condition. Estramustine administration is recommended when the prostate-specific antigen level becomes more than doubled following primary treatment. At a starting prostate-specific antigen level of > 100 ng/ml, the treatment leads to total androgen blockade. If the prostate-specific antigen level has not decreased after treatment for 3 months, the secondary strategy is to apply chemotherapy." @default.
- W2146156310 created "2016-06-24" @default.
- W2146156310 creator A5007028954 @default.
- W2146156310 creator A5010667745 @default.
- W2146156310 creator A5023347600 @default.
- W2146156310 creator A5026324409 @default.
- W2146156310 creator A5033447767 @default.
- W2146156310 creator A5033831714 @default.
- W2146156310 creator A5034711014 @default.
- W2146156310 creator A5038389722 @default.
- W2146156310 creator A5047389152 @default.
- W2146156310 creator A5055208985 @default.
- W2146156310 creator A5058006275 @default.
- W2146156310 creator A5060002630 @default.
- W2146156310 creator A5073333736 @default.
- W2146156310 creator A5076936082 @default.
- W2146156310 date "2005-07-08" @default.
- W2146156310 modified "2023-09-27" @default.
- W2146156310 title "Administration of estramustine in response to changes in the prostate-specific antigen and Karnofsky index in the treatment of prostate cancer." @default.
- W2146156310 cites W1571487648 @default.
- W2146156310 cites W1608221503 @default.
- W2146156310 cites W1885119246 @default.
- W2146156310 cites W1917691562 @default.
- W2146156310 cites W1971351698 @default.
- W2146156310 cites W1984418041 @default.
- W2146156310 cites W1984749582 @default.
- W2146156310 cites W2002827096 @default.
- W2146156310 cites W2019143057 @default.
- W2146156310 cites W2035828101 @default.
- W2146156310 cites W2059972525 @default.
- W2146156310 cites W2061879006 @default.
- W2146156310 cites W2066580649 @default.
- W2146156310 cites W2087884039 @default.
- W2146156310 cites W2090810202 @default.
- W2146156310 cites W2105865588 @default.
- W2146156310 cites W2107531894 @default.
- W2146156310 cites W2108955823 @default.
- W2146156310 cites W2109490785 @default.
- W2146156310 cites W2126048792 @default.
- W2146156310 cites W2136112016 @default.
- W2146156310 cites W2146965174 @default.
- W2146156310 cites W2150056031 @default.
- W2146156310 cites W2160595745 @default.
- W2146156310 cites W2396822460 @default.
- W2146156310 cites W2397424273 @default.
- W2146156310 cites W2401813517 @default.
- W2146156310 cites W2415683488 @default.
- W2146156310 cites W2418606207 @default.
- W2146156310 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15999550" @default.
- W2146156310 hasPublicationYear "2005" @default.
- W2146156310 type Work @default.
- W2146156310 sameAs 2146156310 @default.
- W2146156310 citedByCount "0" @default.
- W2146156310 crossrefType "journal-article" @default.
- W2146156310 hasAuthorship W2146156310A5007028954 @default.
- W2146156310 hasAuthorship W2146156310A5010667745 @default.
- W2146156310 hasAuthorship W2146156310A5023347600 @default.
- W2146156310 hasAuthorship W2146156310A5026324409 @default.
- W2146156310 hasAuthorship W2146156310A5033447767 @default.
- W2146156310 hasAuthorship W2146156310A5033831714 @default.
- W2146156310 hasAuthorship W2146156310A5034711014 @default.
- W2146156310 hasAuthorship W2146156310A5038389722 @default.
- W2146156310 hasAuthorship W2146156310A5047389152 @default.
- W2146156310 hasAuthorship W2146156310A5055208985 @default.
- W2146156310 hasAuthorship W2146156310A5058006275 @default.
- W2146156310 hasAuthorship W2146156310A5060002630 @default.
- W2146156310 hasAuthorship W2146156310A5073333736 @default.
- W2146156310 hasAuthorship W2146156310A5076936082 @default.
- W2146156310 hasConcept C121608353 @default.
- W2146156310 hasConcept C126322002 @default.
- W2146156310 hasConcept C126894567 @default.
- W2146156310 hasConcept C143998085 @default.
- W2146156310 hasConcept C147483822 @default.
- W2146156310 hasConcept C203014093 @default.
- W2146156310 hasConcept C2776235491 @default.
- W2146156310 hasConcept C2777911890 @default.
- W2146156310 hasConcept C2780192828 @default.
- W2146156310 hasConcept C2780201970 @default.
- W2146156310 hasConcept C2781406297 @default.
- W2146156310 hasConcept C2994223898 @default.
- W2146156310 hasConcept C71315377 @default.
- W2146156310 hasConcept C71924100 @default.
- W2146156310 hasConceptScore W2146156310C121608353 @default.
- W2146156310 hasConceptScore W2146156310C126322002 @default.
- W2146156310 hasConceptScore W2146156310C126894567 @default.
- W2146156310 hasConceptScore W2146156310C143998085 @default.
- W2146156310 hasConceptScore W2146156310C147483822 @default.
- W2146156310 hasConceptScore W2146156310C203014093 @default.
- W2146156310 hasConceptScore W2146156310C2776235491 @default.
- W2146156310 hasConceptScore W2146156310C2777911890 @default.
- W2146156310 hasConceptScore W2146156310C2780192828 @default.
- W2146156310 hasConceptScore W2146156310C2780201970 @default.
- W2146156310 hasConceptScore W2146156310C2781406297 @default.
- W2146156310 hasConceptScore W2146156310C2994223898 @default.
- W2146156310 hasConceptScore W2146156310C71315377 @default.
- W2146156310 hasConceptScore W2146156310C71924100 @default.
- W2146156310 hasIssue "4" @default.
- W2146156310 hasLocation W21461563101 @default.